APA (7th ed.) Citation

JD, G., J, C., SM, C., SL, L., DM, B., MA, H., . . . AR, S. (2024). Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design. Journal of cachexia, sarcopenia and muscle, 15(3), 1054. https://doi.org/10.1002/jcsm.13435

Chicago Style (17th ed.) Citation

JD, Groarke, et al. "Phase 2 Study of the Efficacy and Safety of Ponsegromab in Patients with Cancer Cachexia: PROACC-1 Study Design." Journal of Cachexia, Sarcopenia and Muscle 15, no. 3 (2024): 1054. https://doi.org/10.1002/jcsm.13435.

MLA (9th ed.) Citation

JD, Groarke, et al. "Phase 2 Study of the Efficacy and Safety of Ponsegromab in Patients with Cancer Cachexia: PROACC-1 Study Design." Journal of Cachexia, Sarcopenia and Muscle, vol. 15, no. 3, 2024, p. 1054, https://doi.org/10.1002/jcsm.13435.